Je. Buhlmann et al., Cutting edge: Sustained expansion of CD8(+) T cells requires CD154 expression by Th cells in acute graft versus host disease, J IMMUNOL, 162(8), 1999, pp. 4373-4376
Brief treatment with alpha CD154 Ab has been shown to prevent acute graft v
ersus host disease (aGvHD), me extend these data to show that in the absenc
e of CD154 function, donor T cells are unable to expand or generate high le
vel anti-host CTL activity, Using transgenic (Tg) alloreactive CD8(+) T cel
ls adoptively transferred into allogeneic recipients, we show that short-te
rm expansion of the CD8(+) Tg T cells occurred in the absence of Th cells,
and this short-term expansion could be facilitated with an agonistic alpha
CD40. While CD40 agonism could enhance short-term expansion, sustained expa
nsion of CD8(+) Tg T cells required bona fide CD154-expressing CD4(+) allor
eactive Th cells. While CD154 was necessary for CD8(+) Tg T cell sustained
expansion, IL-2 was also implicated as essential. These observations sugges
t alpha CD154 therapy in GvHD is effective because the treatment causes an
abortive CD8 alloresponse leading to the exhaustion or deletion of alloreac
tive CD8(+) clones preventing the development of disease.